Topiramate Tablet, Film Coated
Product Images NDC 80425-0092

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

The text provides the Cumulative Rates for Time to First Seizure for two groups that were given different dosages of Topiramate. The group that received 400mg/day had a significantly lower rate of seizure occurrence compared to the group that received 50mg/day according to the P-value provided. The graph displays the time in days on the x-axis and the cumulative rate on the y-axis.*

FDA Label Image

Fig 2

This is a table showing the change in average monthly migraine period rate from baseline to double-blind phase in different groups receiving different doses of Topiramate and placebo. The table also includes sample size and p-values.*

FDA Label Image

Structure

FDA Label Image

Topiramate 50mg Tab Qty 60 Ndc 80425 0092

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.